federal_register: 2022-26567

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2022-26567 Homeopathic Drug Products; Guidance for Food and Drug Administration Staff and Industry; Availability Notice The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for FDA staff and industry entitled "Homeopathic Drug Products." The guidance describes how FDA intends to prioritize enforcement and regulatory action with regard to drug products, including biological products, labeled as homeopathic and marketed in the United States without the required FDA approval. 2022-12-07 2022 12 https://www.federalregister.gov/documents/2022/12/07/2022-26567/homeopathic-drug-products-guidance-for-food-and-drug-administration-staff-and-industry-availability https://www.govinfo.gov/content/pkg/FR-2022-12-07/pdf/2022-26567.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for FDA staff and industry entitled "Homeopathic Drug Products." The guidance describes how FDA intends to prioritize enforcement and regulatory...  

Links from other tables